Secura Bio Announces U.S. Withdrawal of Farydak (panobinostat) NDA

3 years ago

by David Miller

948 Views

Written by David Miller

SUMMERLIN, Nev., Nov. 30, 2021 /PRNewswire/ — Secura Bio, Inc. (Secura Bio) – (www.securabio.com), an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impactful oncology therapies, announced today…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!